GiannakopoulosBKrilisSA. The pathogenesis of the antiphospholipid syndrome. N Engl J Med2013; 368(11): 1033–1044.
2.
Erkan D, Lockshin MD (eds). Antiphospholipid syndrome: Current research highlights and clinical insights. New York: Springer, 2017.
3.
GoffDCJr.Lloyd-JonesDMBennettGet al.2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol2014; 63(25 Pt B): 2935–2959.
4.
StoneNJRobinsonJGLichtensteinAHet al.2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol2014; 63(25 Pt B): 2889–2934.
5.
BarbhaiyaMErkanD. Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?Curr Rheumatol Rep2011; 13(1): 59–69.
6.
Bibbins-DomingoK. Force USPST. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med2016; 164(12): 836–845.
